Regulation of cytokine signaling by the SOCS and Spred family proteins

Keio Journal of Medicine

Volumn 58, Issue 2, 2009, Pages 73-83

  Yoshimura, Akihiko ^a,b  

^a KEIO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cytokine; Negative regulation; Signal transduction

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; RAF PROTEIN; RAS PROTEIN; SPRED 1 PROTEIN; SPRED PROTEIN; SPROUTY PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTHRITIS; CARCINOGENESIS; CELL DIFFERENTIATION; DENDRITIC CELL; ENZYME ACTIVATION; GENE TARGETING; GENERAL ASPECTS OF DISEASE; HEMATOPOIESIS; HEPATITIS; HUMAN; INFLAMMATORY DISEASE; INNATE IMMUNITY; LIVER INJURY; LYMPHANGIOGENESIS; NONHUMAN; PHYSIOLOGY; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE;

ANIMALS; CYTOKINES; DENDRITIC CELLS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; NEOPLASMS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOLL-LIKE RECEPTORS;

EID: 68049135501     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.58.73     Document Type: Review

References (62)

1. Ward AC, Touw I, Yoshimura A: The jak-stat pathway in normal and perturbed hematopoiesis. Blood 2000; 95: 19-29 (Pubitemid 30017220)
2. Hanada T, Yoshimura A: Regulation of cytokine signaling and inflammation. Cytokine and Growth Factor Reviews 2002; 13: 413-421
3. Hara T, Miyajima A: Function and signal transduction mediated by the interleukin 3 receptor system in hematopoiesis. Stem Cells 1996; 14: 605-618 (Pubitemid 26404613)
4. Yoshimura A, Misawa H: Physiology and function of the erythropoietin receptor. Curr Opin Hematol 1998; 5:171-176
5. Miranda MB, Xu H, Torchia JA, Johnson DE: Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ ERK pathway. Leuk Res 2005; 29: 1293-1306 (Pubitemid 41297642)
6. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanekura Y, Komiya S, Yoshimura A: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387: 921-924 (Pubitemid 27289595)
7. Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K, Tsuneoka M, Komiya S, Baron R, Yoshimura A: Spred, a Sprouty-related suppressor of Ras signaling. Nature 2001; 412: 647-651 (Pubitemid 32772277)
8. Kubo M, Hanada T, Yoshimura A: Suppressors of cytokine signaling and immunity. Nature Immunol 2003; 4: 1169-1176
9. Naka T, Fujimoto M, Tsutsui H, Yoshimura A: Regulation of cytokine and TLR signalings by SOCS and others. Adv Immunol 2005; 87: 61-122 (Pubitemid 41135899)
10. Yoshimura A, Naka T, Kubo M: SOCS proteins, cytokine signaling and immune regulation. Nat Rev Immunol 2007; 7: 454-465 (Pubitemid 46834848)
11. Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, Hattori K, Morita S, Kitamura T, Kato H, Nakayama K, Yoshimura A: The SOCS box of SOCS-1 accelerates ubiquitin- dependent proteolysis of TEL-JAK2. J Biol Chem 2001; 276: 12530-12538 (Pubitemid 37385161)
12. Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka A, Imaizumi T, Matsuda T, Ihle JN, Yoshimura A: The JAK-Binding Protein JAB Inhibits Janus Tyrosine Kinase Activity Through Binding in the Activation Loop. EMBO J 1999; 18: 1309-1320 (Pubitemid 29110315)
13. Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I, Yoshimura A: CIS3/SOCS3 suppresses erythropoietin signaling by binding the EPO receptor and JAK2. J Biol Chem 2000; 275: 29338-29347 (Pubitemid 32043805)
14. Behrmann I, Tsiaris W, Sasaki A, Schneider-Mergener J, Yoshimura A, Neel BG, Heinrich PC, Schaper F: SHP2 and SOCS3 contribute to Y759-dependent attenuation of IL-6-signaling through gp130. J Biol Chem 2003; 278: 661-671 (Pubitemid 36043620)
15. Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, Hanada T, Takeda K, Akira S, Hoshijima M, Hirano T, Chien KR, Yoshimura A: IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nature Immunol 2003; 4: 551-556 (Pubitemid 36701338)
16. Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, Sasaki M, Johnston JA, Yoshimura A: Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 1999; 4: 339-351 (Pubitemid 29359449)
17. Marine J-C, Topham DJ, McKay C, Wang D, Parganas E, Stravopodis D, Yoshimura A, Ihle JN: SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality. Cell 1999; 98: 609-616 (Pubitemid 29418952)
18. Torisu T, Nakaya M, Watanabe S, Hashimoto M, Yoshida H, Chinen T, Yoshida R, Okamoto F, Hanada T, Torisu K, Takaesu G, Kobayashi T, Yasukawa H, Yoshimura A: Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis. Hepatology 2008; 47: 1644-1654 (Pubitemid 351702747)
19. Horino J, Fujimoto M, Terabe F, Serada S, Takahashi T, Soma Y, Tanaka K, Chinen T, Yoshimura A, Nomura S, Kawase I, Hayashi N, Kishimoto T, Naka T: Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice. Int Immunol 2008; 20: 753-762 (Pubitemid 351791519)
20. Tanaka K, Ichiyama K, Hashimoto M, Yoshida H, Takimoto T, Takaesu G, Torisu T, Hanada T, Yasukawa H, Fukuyama S, Inoue H, Nakanishi Y, Kobayashi T, Yoshimura A: Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-gamma on STAT3 and Smads. J Immunol 2008; 180: 3746-3756
21. Takahashi Y, Dominici M, Swift J, Nagy C, Ihle JN: Trophoblast stem cells rescue placental defect in SOCS3-deficient mice. J Biol Chem 2006; 281: 11444-11445 (Pubitemid 43855397)
22. Kimura A, Kinjyo I, Matsumura Y, Mori H, Mashima R, Harada M, Chien KR, Yasukawa H, Yoshimura A: SOCS3 is a physiological negative regulator for granulopoiesis and G-CSF receptor signaling. J Biol Chem 2004; 297: 6905-6910
23. Lee CK, Raz R, Gimeno R, Gertner R, Wistinghausen B, Takeshita K, DePinho RA, Levy DE: STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 2002; 17: 63-72
24. Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, Torisu T, Chien KR, Yasukawa H, Yoshimura A: SOCS3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity Nature Medicine 2004; 10: 739-743
25. Kievit P, Howard JK, Badman MK, Balthasar N, Coppari R, Mori H, Lee CE, Elmquist JK, Yoshimura A, Flier JS: Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab 2006; 4: 123-132 (Pubitemid 44138722)
26. Shi H, Tzameli I, Bjorbaek C, Flier JS: Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem 2004; 279: 34733-34740 (Pubitemid 39318104)
27. Torisu T, Sato N, Yoshiga D, Kobayashi T, Yoshioka T, Mori H, Iida M, Yoshimura A: The dual function of hepatic SOCS3 in insulin resistance in vivo. Genes Cells 2007; 12: 143-154. (Pubitemid 46152654)
28. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, Ohishi M, Yoshida H, Kubo M, Yoshimura A: SOCS1/JAB Is a Negative Regulator of LPS-Induced Macrophage Activation. Immunity 2002; 17: 583-591 (Pubitemid 35351504)
29. Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ, Nicholson SE, Hilton DJ, O'Neill LA, Hertzog PJ: Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 2006; 7: 148-155
30. Kimura A, Naka T, Muta T, Takeuchi O, Akira S, Kawase I, Kishimoto T: Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. Proc Natl Acad Sci USA 2005; 102: 17089-17094 (Pubitemid 41692688)
31. Hanada T, Yoshida H, Kato S, Tanaka K, Masutani K, Tsukada J, Nomura Y, Mimata H, Kubo M, Yoshimura A: Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 2003; 19: 437-450 (Pubitemid 37153419)
32. Evel-Kabler K, Song XT, Aldrich M, Huang XF, Chen SY: SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumour immunity by regulating IL-12 production and signaling. J Clin Invest 2006; 116: 90-100 (Pubitemid 43121794)
33. Hanada T, Tanaka K, Matsumura Y, Yamauchi M, Nishinakamura H, Aburatani H, Mashima R, Kubo M, Kobayashi T, Yoshimura A: Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J Immunol 2005; 174: 4325-4332 (Pubitemid 40396015)
34. Shen L, Evel-Kabler K, Strube R, Chen SY: Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumour immunity. Nat Biotechnol 2004; 22: 1546-1553 (Pubitemid 40039457)
35. Chinen T, Kobayashi T, Ogata H, Takaesu G, Takaki H, Hashimoto M, Yagita H, Nawata H, Yoshimura A: Suppressor of Cytokine Signaling-1 Regulates Inflammatory Bowel Disease in Which Both IFNgamma and IL-4 Are Involved. Gastroenterology 2006; 130: 373-388 (Pubitemid 43202037)
36. Matsumura Y, Kobayashi T, Ichiyama K, Yoshida R, Hashimoto M, Takimoto T, Tanaka K, Chinen T, Shichita T, Wyss-Coray T, Sato K, Yoshimura A: Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J Immunol 2007; 179: 2170-2179
37. Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, Koga K, Takaki H, Himeno K, Takaesu G, Kobayashi T, Yoshimura A: Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J Exp Med 2006; 203: 1021-1031
38. Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H, Iida M, Kobayashi T, Yoshimura A: Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 2006; 25: 2520-2530
39. Li Y, Chu N, Rostami A, Zhang GX: Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 2006; 177: 1679-1688 (Pubitemid 44092504)
40. Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A: CIS3/SOCS3/ SSI3 Plays a Negative Regulatory Role in STAT3 Activation and Intestinal Inflammation. J Exp Med 2001; 193: 471-482 (Pubitemid 32524478)
41. Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K, Komiya S, Kosai K, Hanakawa Y, Hashimoto K, Nagata K, Yoshimura A: Induction of the cytokine signal regulator SOCS3/ CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 2001; 108: 1781-1788 (Pubitemid 34015123)
42. Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, Yoshimura A, Hennighausen L, O'Shea JJ: Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci USA 2006; 103: 8137-8142 (Pubitemid 43801065)
43. Seki Y, Inoue H, Nagata N, Hayashi K, Fukuyama S, Matsumoto K, Komine O, Hamano S, Himeno K, Inagaki-Ohara K, Cacalano N, O'Garra A, Oshida T, Saito H, Johnston JA, Yoshimura A, Kubo M: SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses. Nature Medicine 2003; 9: 1047-1054 (Pubitemid 37021785)
44. Yoshida T, Ogata H, Kamio M, Joo A, Shiraishi H, Tokunaga Y, Sata M, Nagai H, Yoshimura A: SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. J Exp Med 2004; 199: 1701-1707 (Pubitemid 38822003)
45. Ogata H, Kobayashi T, Chinen T, Takaki H, Sanada T, Minoda Y, Koga K, Takaesu G, Maehara Y, Iida M, Yoshimura A: Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 2006; 131: 179-193 (Pubitemid 44015756)
46. Hanada T, Kobayashi T, Chinen T, Saeki K, Takaki H, Koga K, Minoda Y, Sanada T, Yoshioka T, Mimata H, Kato S, Yoshimura A: IFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. J Exp Med 2006; 203: 1391-1397 (Pubitemid 43877600)
47. Yoshimura A: Signal transduction of inflammatory cytokines and tumour development.Cancer Sci 2006; 97: 439-447
48. Sasaki A, Taketomi T, Wakioka T, Kato R, Yoshimura A: Identification of a dominant negative form of Sproutys that potentiates FGF- but not EGF-induced ERK activation. J Biol Chem 2001; 276: 36804-36808
49. Kato R, Nonami A, Taketomi T, Wakioka T, Kuroiwa A, Matsuda Y, Yoshimura A: Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation. Biochem Biophys Res Commun 2003; 302: 767-772 (Pubitemid 36294039)
50. Sasaki A, Taketomi T, Kato R, Saeki K, Nonami A, Sasaki M, Kuriyama M, Saito N, Shibuya M, Yoshimura A: Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nature Cell Biol 2003; 5: 427-432 (Pubitemid 36592265)
51. Taketomi T, Yoshiga D, Taniguchi K, Kobayashi T, Nonami A, Kato R, Sasaki M, Sasaki A, Ishibashi H, Moriyama M, Nakamura KI, Nishimura J, Yoshimura A: Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia. Nature Neurosci 2005; 8: 855-857
52. Taniguchi K, Ayada T, Ichiyama K, Kohno R, Yonemitsu Y, Minami Y, Kikuchi A, Maehara Y, Yoshimura A: Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling. Biochem Biophys Res Commun 2007; 352: 896-902 (Pubitemid 44895609)
53. Nonami A, Kato R, Taniguchi K, Yoshiga D, Taketomi T, Fukuyama S, Harada M, Sasaki A, Yoshimura A:Spred-1 negatively regulates interleukin-3-mediated ERK/mitogen-activated protein (MAP) kinase activation in hematopoietic cells. J Biol Chem 2004; 279: 52543-52551 (Pubitemid 39656630)
54. Inoue H, Kato R, Fukuyama S, Nonami A, Taniguchi K, Matsumoto K, Nakano T, Tsuda M, Matsumura M, Kubo M, Ishikawa F, Moon BG, Takatsu K, Nakanishi Y, Yoshimura A: Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness. J Exp Med 2005; 201: 73-82 (Pubitemid 40130085)
55. Nobuhisa I, Kato R, Inoue H, Takizawa M, Okita K, Yoshimura A, Taga T: Spred-2 Suppresses Aorta-Gonad-Mesonephros Hematopoiesis by Inhibiting MAP Kinase Activation. J Exp Med 2004; 199: 737-742 (Pubitemid 38316441)
56. Nonami A, Taketomi T, Kimura A, Saeki K, Takaki H, Sanada T, Taniguchi K, Harada M, Kato R, Yoshimura A: The Sprouty-related protein, Spred-1, localizes in a lipid raft/caveola and inhibits ERK activation in collaboration with caveolin-1. Genes Cells 2005; 10: 887-895 (Pubitemid 41246017)
57. Taniguchi K, Kohno R, Ayada T, Kato R, Ichiyama K, Morisada T, Oike Y, Yonemitsu Y, Maehara Y, Yoshimura A: Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol Cell Biol 2007; 27: 4541-4550. Epub 2007 Apr 16 (Pubitemid 46906575)
58. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN: The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008; 15: 261-271
59. Bentires-Alj M, Kontaridis MI, Neel BG: Stops along the RAS pathway in human genetic disease. Nat Med 2006; 12: 283-285 (Pubitemid 43355073)
60. Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns JP, Cools J, Marynen P, Thomas G, Yoshimura A, Legius E: Germline loss-of- function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nature Genet 2007; 39: 1120-1126. Epub 2007 Aug 19 (Pubitemid 47340658)
61. Yoshida T, Hisamoto T, Akiba J, Koga H, Nakamura K, Tokunaga Y, Hanada S, Kumemura H, Maeyama M, Harada M, Ogata H, Yano H, Kojiro M, Ueno T, Yoshimura A, Sata M: Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumours. Oncogene 2006; 25: 6056-6066 (Pubitemid 44562404)
62. Miyoshi K, Wakioka T, Nishinakamura H, Kamio M, Yang L, Inoue M, Hasegawa M, Yonemitsu Y, Komiya S, Yoshimura A: The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization. Oncogene 2004; 23: 5567-5576 (Pubitemid 39093034)